S1PR1 and multiple sclerosis: For example, fingolimod (FTY720), a drug that induces sphingosine-1-phosphate receptor (S1PR1) down-modulation and inhibits egress of T cells from lymphoid tissues [126], is commonly used for treatment of multiple sclerosis [127].